Corrigendum to “Efficacy and safety of ZX-7101A, an inhibitor of influenza cap-dependent endonuclease, in adults with uncomplicated influenza: a randomized, double-blind, placebo-controlled phase 2/3 trial” [Clin Microbiol Infect 31 (2025) 274–281]
Saved in:
Published in | Clinical microbiology and infection Vol. 31; no. 5; pp. 880 - 881 |
---|---|
Main Authors | , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
England
Elsevier Ltd
01.05.2025
|
Online Access | Get full text |
Cover
Loading…
Bibliography: | erratum |
---|---|
ISSN: | 1198-743X 1469-0691 |
DOI: | 10.1016/j.cmi.2025.02.014 |